Table 2. Clinicopathological characteristics of TCGA HCC patients.
| HCC cases (n = 316) | Adjacent non-tumorous tissues (n = 40) | |||
|---|---|---|---|---|
| No. | % | No. | % | |
| Gender | ||||
| Male | 216 | 68.4 | 22 | 55 |
| Female | 100 | 31.6 | 18 | 45 |
| Age (Mean ± SD) (y/o) | 59.6 ± 13 | 59.9 ± 12.9 | ||
| Pathologic_stage | ||||
| I | 160 | 50.6 | 18 | 45 |
| II | 73 | 23.1 | 9 | 22.5 |
| III | 80 | 25.3 | 12 | 30 |
| IV | 3 | 1 | 1 | 2.5 |
| Pathology_T_stage | ||||
| t1 | 160 | 50.6 | 19 | 47.5 |
| t2 | 74 | 23.4 | 9 | 22.5 |
| t3 | 72 | 22.8 | 12 | 30 |
| t4 | 9 | 2.9 | 0 | 0 |
| NA | 1 | 0.3 | 0 | 0 |
| Pathology_N_stage | ||||
| n0 | 231 | 73.1 | 30 | 75 |
| n1 | 3 | 1 | 1 | 2.5 |
| nx | 81 | 25.6 | 8 | 20 |
| NA | 1 | 0.3 | 1 | 2.5 |
| Pathology_M_stage | ||||
| m0 | 240 | 75.9 | 31 | 77.5 |
| m1 | 3 | 1 | 1 | 2.5 |
| mx | 73 | 23.1 | 8 | 20 |
| Residual_tumor | ||||
| r0 | 280 | 88.6 | 34 | 85 |
| r1 | 12 | 3.8 | 0 | 0 |
| r2 | 1 | 0.3 | 1 | 2.5 |
| rx | 16 | 5.1 | 3 | 7.5 |
| NA | 7 | 2.2 | 2 | 5 |
| Radiation_therapy | ||||
| No | 292 | 92.4 | 31 | 77.5 |
| Yes | 9 | 2.9 | 2 | 5 |
| NA | 15 | 4.7 | 4 | 10 |
| Race | ||||
| american indian or alaska native | 1 | 0.3 | 0 | 0 |
| asian | 145 | 45.9 | 5 | 12.5 |
| black or african american | 13 | 4.1 | 6 | 15 |
| white | 8 | 2.5 | 26 | 65 |
| NA | 149 | 47.2 | 3 | 7.5 |
| Ethnicity | ||||
| hispanic or latino | 15 | 4.7 | 0 | 0 |
| not hispanic or latino | 289 | 91.5 | 36 | 90 |
| NA | 12 | 3.8 | 4 | 10 |